Overseas Firms Struggle With Software Protocols During U.S. FDA Inspections – Bio Korea
This article was originally published in The Pink Sheet Daily
Executive Summary
Compliance with 21 CFR Part 11 of U.S. regulation covering management procedures for software used in clinical trials is at issue.